Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04956354
Other study ID # 2022-7704
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 15, 2022
Est. completion date July 2024

Study information

Verified date June 2023
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact Guilherme M Sant'Anna, MD PhD
Phone (514)-412-4400
Email guilherme.santanna@mcgill.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will be conducted in a convenience sample of 75 infants admitted to the NICU at the Montreal Children's Hospital, divided into 3 phases: (a) Phase 1a - monitoring for 8h per day for 4 consecutive days, (b) Phase 1b - monitoring between 2h to 8h per day for 2 to 4 consecutive days, and (c) Phase 2- monitoring for 96h continuously. Study objectives include: 1. Demonstrate the feasibility of continuous wireless monitoring in term and preterm infants with variable degrees of maturation and acuity in the NICU. 2. Assess safety of using a special wireless sensor system in neonates. 3. Evaluate the accuracy of proposed wireless technology as compared to standard monitoring technology in the NICU.


Description:

Infants admitted in the NICU are all subject to continuous monitoring of vital signs such as heart rate, respirations and oxygen saturation (SpO2) by placing sensors, leads, or bands directly on infant's skin and connecting them to monitors via wires. However, despite the rapid technological advances in wireless monitoring and wearable devices across various industries, the health care sector has traditionally lagged. Therefore, the investigators aim to explore the safety and effectiveness of wireless monitoring (ANNE™ Monitoring System) and compare it with the traditional wired monitoring system on infants with variable degrees of maturity in the NICU. More specifically, the investigators aim to examine (1) if it is feasible and to implement a wireless monitoring system in both term and preterm infants in the NICU; (2) if it is safe to use this particular wireless monitoring system among neonates; and (3) the accuracy of the wireless monitoring technology compared to the stand-of-care monitoring in the NICU.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date July 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Hours to 1 Month
Eligibility Inclusion Criteria: - Healthy term infants in room air at enrollment - Term infants with perinatal asphyxia undergoing therapeutic hypothermia at enrollment - Healthy preterm infants in room air at enrollment - Preterm infants on continuous positive airway pressure at enrollment - Preterm infants on conventional mechanical ventilation at enrollment - Preterm infants on high frequency ventilation at enrollment - Preterm infants on nasal intermittent positive end expiratory pressure at enrollment - Preterm infants on continuous positive airway pressure at enrollment Exclusion Criteria: - Congenital anomalies and surgical conditions (ex: gastroschisis, omphalocele, congenital diaphragmatic hernia) - Congenital heart disorders - Congenital skin infections or known conditions with fragile skin (such as epidermolysis bullosa)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ANNE™ Monitoring System (2 sensors) - version B
ANNE™ is a wireless vital sign monitoring device that uses soft, flexible, skin-mountable biosensors (ANNE™ Chest and ANNE™ Limb) with Bluetooth® 5 enabled and encrypted data communication to an iPad application. Study sensors to be applied on patients are: Sensor 1 - A chest unit (ANNE™ Chest) with embedded battery, sensors, and a three-axis accelerometer that captures the following signals: electrocardiography (ECG), temperature, seismocardiography (SCG) and the chest wall movements. Sensor 2 - A limb unit (ANNE™ Limb) with embedded battery that captures the photoplethysmography (PPG) and SpO2 signals.
ANNE™ Monitoring System (2 sensors) - version C
ANNE™ is a wireless vital sign monitoring device that uses soft, flexible, skin-mountable biosensors (ANNE™ Arc and ANNE™ Limb) with Bluetooth® 5 enabled and encrypted data communication to an iPad application. Study sensors to be applied on patients are: Sensor 1 - ANNE™ Arc with a Lithium-Polymer battery that contains a 6-axial inertial measurement unit (IMU), which includes a 3-axis gyroscope and 3-axis accelerometer, a power management component, an analog front-end component, passive electrodes for ECG, and bio-impedance feature that capture the following waveforms: heart rate (HR), respiratory rate (RR) and skin temperature. Sensor 2 - A limb unit (ANNE™ Limb) with embedded battery that captures the photoplethysmography (PPG) and SpO2 signals.
ANNE™ Monitoring System (2 sensors) - version C
ANNE™ is a wireless vital sign monitoring device that uses soft, flexible, skin-mountable biosensors (ANNE™ Arc and ANNE™ Limb) with Bluetooth® 5 enabled and encrypted data communication to an iPad application. Study sensors to be applied on patients are: Sensor 1 - ANNE™ Arc with a Lithium-Polymer battery that contains a 6-axial inertial measurement unit (IMU), which includes a 3-axis gyroscope and 3-axis accelerometer, a power management component, an analog front-end component, passive electrodes for ECG, and bio-impedance feature that capture the following waveforms: heart rate (HR), respiratory rate (RR) and skin temperature. Sensor 2 - A limb unit (ANNE™ Limb) with embedded battery that captures the photoplethysmography (PPG) and SpO2 signals.

Locations

Country Name City State
Canada Montreal Children's Hospital Montréal Quebec

Sponsors (3)

Lead Sponsor Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre McGill University, Northwestern University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of wireless wearable heart rate data Accuracy of wireless wearable heart rate data compared against the current standards of NICU bedside monitoring. 4 consecutive days of wireless monitoring
Primary Accuracy of wireless wearable respiratory rate data Accuracy of wireless wearable respiratory rate data compared against the current standards of NICU bedside monitoring. 4 consecutive days of wireless monitoring
Primary Accuracy of wireless wearable skin temperature data Accuracy of wireless wearable skin temperature data compared against the current standards of NICU bedside monitoring. 4 consecutive days of wireless monitoring
Primary Accuracy of wireless wearable oxygen saturation (SpO2) data Accuracy of wireless wearable SpO2 data compared against the current standards of NICU bedside monitoring. 4 consecutive days of wireless monitoring
Primary Proportion of time exhibiting unreliable wireless device signals due to significant movement artifacts Proportion of monitoring time exhibiting unreliable wireless device signals due to significant movement artifacts. The exact definition of unreliable for each of the signals will be outlined before study initiation. 4 consecutive days of wireless monitoring
Primary Proportion of time with loss of network connections or other technical problems Proportion of time with loss of network connections or other technical problems from the wireless wearables vs. the NICU bedside monitoring. 4 consecutive days of wireless monitoring
Primary Skin integrity at the sites of sensor placement Skin integrity at the site of wireless lead placements from de-identified digital photographs, evaluated by a board-certified dermatologist who will evaluate for signs of irritation, redness and/or erosions. 4 consecutive days of wireless monitoring
Primary Evaluation of potential subjective pain experienced by infant at time of sensor removal Assessing infants for presence of acute pain associated with sensor removal by administering Neonatal Infant Pain Scale (NIPS) at time of device removal. 4 consecutive days of wireless monitoring
Primary Clinicians', nursing, and parental perceptions Clinicians', nursing, and parental perceptions of the implementation of wireless wearable devices in the NICU. 4 consecutive days of wireless monitoring
Secondary Automated reports of physiological health - electrocardiogram Automated reports for electrocardiogram acquired from the wireless monitoring device 4 consecutive days of wireless monitoring
Secondary Automated reports of physiological health - respiratory waveforms Automated reports for respiratory waveforms acquired from the wireless monitoring device 4 consecutive days of wireless monitoring
Secondary Automated reports of physiological health - oxygen saturation Automated reports for oxygen saturation acquired from the wireless monitoring device 4 consecutive days of wireless monitoring
Secondary Automated reports of physiological health - temperature Automated reports for temperature acquired from the wireless monitoring device 4 consecutive days of wireless monitoring
Secondary Comparison between chest and respiratory inductance plethysmography (RIP) and the wireless monitoring device For patients in Cohort 2, we will compare the chest and abdominal wall movement signals derived from accelerometry with RIP (the gold standard) with the simultaneously recorded wireless monitoring device data. 2 to 3 consecutive hours each day during the 4-day continuous monitoring
Secondary Enhanced respiratory monitoring using accelerometry For patients in Cohort 2, we will compare the chest and abdominal wall movement signals derived from accelerometry with thoracic impedance (the current standard) with the simultaneously recorded wireless monitoring device data. 2 to 3 consecutive hours each day during the 4-day continuous monitoring
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04811742 - Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn N/A